1. Home
  2. HITI vs NERV Comparison

HITI vs NERV Comparison

Compare HITI & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Tide Inc.

HITI

High Tide Inc.

HOLD

Current Price

$2.31

Market Cap

189.8M

Sector

N/A

ML Signal

HOLD

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.20

Market Cap

210.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HITI
NERV
Founded
2009
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.8M
210.1M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
HITI
NERV
Price
$2.31
$4.20
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$6.13
$10.50
AVG Volume (30 Days)
315.1K
151.9K
Earning Date
06-15-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,175,600.00
Revenue This Year
$23.73
N/A
Revenue Next Year
$12.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.02
$1.76
52 Week High
$4.06
$12.46

Technical Indicators

Market Signals
Indicator
HITI
NERV
Relative Strength Index (RSI) 58.10 51.96
Support Level $2.20 $3.80
Resistance Level $2.60 $4.70
Average True Range (ATR) 0.08 0.34
MACD 0.02 0.03
Stochastic Oscillator 68.35 71.08

Price Performance

Historical Comparison
HITI
NERV

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: